Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Income from Non-Controlling Interests (2020 - 2025)

Apyx Medical (APYX) has disclosed Income from Non-Controlling Interests for 9 consecutive years, with $59000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Non-Controlling Interests rose 290.32% year-over-year to $59000.0, compared with a TTM value of $106000.0 through Dec 2025, up 210.42%, and an annual FY2025 reading of $106000.0, up 210.42% over the prior year.
  • Income from Non-Controlling Interests was $59000.0 for Q4 2025 at Apyx Medical, up from $29000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $59000.0 in Q4 2025 and bottomed at -$49000.0 in Q1 2023.
  • Average Income from Non-Controlling Interests over 5 years is -$12450.0, with a median of -$19000.0 recorded in 2023.
  • The sharpest move saw Income from Non-Controlling Interests tumbled 475.0% in 2022, then soared 290.32% in 2025.
  • Year by year, Income from Non-Controlling Interests stood at -$7000.0 in 2021, then crashed by 128.57% to -$16000.0 in 2022, then fell by 6.25% to -$17000.0 in 2023, then tumbled by 82.35% to -$31000.0 in 2024, then skyrocketed by 290.32% to $59000.0 in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for APYX at $59000.0 in Q4 2025, $29000.0 in Q3 2025, and $40000.0 in Q2 2025.